Changes of Fas and Fas ligand immunoreactivity after compression trauma to rat spinal cord

被引:57
作者
Li, GL [1 ]
Farooque, M [1 ]
Olsson, Y [1 ]
机构
[1] Univ Uppsala Hosp, Dept Genet & Pathol, Res Grp Neuropathol, S-75185 Uppsala, Sweden
关键词
Fas; Fas ligand; rat; spinal cord; trauma;
D O I
10.1007/s004010051195
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This immunohistochemical study evaluated Fas and Fas ligand (FasL) in the rat nervous system and their changes in the spinal cord subjected to compression. Normal spinal cord showed a low level of Fas and Fast immunoreactivity in the white matter except in the corticospinal tracts. Fas and Fast immunoreactivity seemed to be located in axons and their myelin sheaths. Other regions of the nervous system did not show immunoreactivity to Fas and Fast. Moderate and severe compression injury of the spinal cord resulted in a reduction of Fas and Fast immunoreactivity in the white matter of injured T8-9 segments at 4 h and a complete loss at 1 day after trauma. This was seen even in the remaining white matter. In contrast, increased immunoreactivity to Fas and Fast was present in the cranial T7, caudal T10 (moderate injury) and T12 (severe injury) segments at day 4 with most intense staining were seen at day 9 after trauma. Increased Fas and Fast immunoreactivity may have pathophysiological implications for the development of secondary injuries after trauma to the spinal cord. Fas-FasL interactions may for instance be involved in apoptosis of oligodendrocytes which occurs as a delayed phenomenon after trauma to the spinal cord. The integrity of myelin sheaths may in this way be jeopardized by apoptosis of oligodendrocytes.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 34 条
  • [1] AGGARWAL BB, 1995, FEBS LETT, V363, P5
  • [2] CELL-DEATH AND CONTROL OF CELL-SURVIVAL IN THE OLIGODENDROCYTE LINEAGE
    BARRES, BA
    HART, IK
    COLES, HSR
    BURNE, JF
    VOYYODIC, JT
    RICHARDSON, WD
    RAFF, MC
    [J]. CELL, 1992, 70 (01) : 31 - 46
  • [3] Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity
    Becher, B
    D'Souza, SD
    Troutt, AB
    Antel, JP
    [J]. NEUROSCIENCE, 1998, 84 (02) : 627 - 634
  • [4] Bonetti B, 1997, J IMMUNOL, V159, P5733
  • [5] Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis
    Bonetti, B
    Raine, CS
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (01) : 74 - 84
  • [6] Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
    Crowe, MJ
    Bresnahan, JC
    Shuman, SL
    Masters, JN
    Beattie, MS
    [J]. NATURE MEDICINE, 1997, 3 (01) : 73 - 76
  • [7] Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
    Dowling, P
    Shang, GF
    Raval, S
    Menonna, J
    Cook, S
    Husar, W
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1513 - 1518
  • [8] IN-SITU EVIDENCE FOR DNA FRAGMENTATION IN HUNTINGTONS-DISEASE STRIATUM AND ALZHEIMERS-DISEASE TEMPORAL LOBES
    DRAGUNOW, M
    FAULL, RLM
    LAWLOR, P
    BEILHARZ, EJ
    SINGLETON, K
    WALKER, EB
    MEE, E
    [J]. NEUROREPORT, 1995, 6 (07) : 1053 - 1057
  • [9] Multiple sclerosis: Fas signaling in oligodendrocyte cell death
    DSouza, SD
    Bonetti, B
    Balasingam, V
    Cashman, NR
    Barker, PA
    Troutt, AB
    Raine, CS
    Antel, JP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) : 2361 - 2370